Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07446894) titled 'MSA-01 in Multiple System Atrophy' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Tokyo University

Condition: Multiple System Atrophy (MSA)

Intervention: Drug: MSA-01

Recruitment Status: Recruiting

Phase: Phase 3

Date of First Enrollment: February 9, 2026

Target Sample Size: 140

Countries of Recruitment: Japan

To know more, visit https://clinicaltrials.gov/study/NCT07446894

Published by HT Digital Content...